This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Coimbra, R. Articles by Rocha-e-Silva, M. Search for Related Content PubMed PubMed Citation Articles by Coimbra, R. Articles by Rocha-e-Silva, M. Related Collections Cardiovascular Critical Care Heart Resuscitation Pharmacology

---

CRITICAL CARE AND TRAUMA

Intraarterial Pulmonary Pentoxifylline Improves Cardiac Performance and Oxygen Utilization After Hemorrhagic Shock: A Novel Resuscitation Strategy

Raul Coimbra, MD PhD^*, Alvaro Razuk-Filho, MD PhD, Margareth M. Yada-Langui, BS, and Mauricio Rocha-e-Silva, MD PhD

*Division of Trauma, Department of Surgery, University of California San Diego School of Medicine, San Diego, California; Santa Casa School of Medicine, São Paulo, Brazil; and Research Division, Heart Institute (InCor), University of São Paulo, São Paulo, Brazil

Address correspondence and reprint requests to Raul Coimbra, MD, PhD, Division of Trauma, Surgical Critical Care, and Burns, University of California San Diego School of Medicine, 200 W. Arbor Dr., #8896, San Diego, CA 921038896. Address e-mail to rcoimbra{at}ucsd.edu

The role of pentoxifylline (PTX) as a resuscitation adjunct in hemorrhagic shock is unclear. PTX infusion into the pulmonary artery and its effects on cardiac performance and oxygen utilization have not been defined. We hypothesized that pulmonary PTX is superior to systemic PTX or lactated Ringer’s (LR) solution alone. The effects of LR solution, systemic PTX, and pulmonary PTX on cardiac performance and oxygen utilization in a hemorrhagic shock model in dogs were compared. Animals were bled to a mean arterial blood pressure (MAP) of 40 mm Hg maintained for 30 min and randomized into 3 resuscitation groups: LR solution (2x shed blood), systemic PTX (10 mg/kg bolus IV) in addition to LR solution (2x shed blood) + PTX (5 mg/kg for 45 min IV), and pulmonary PTX (10 mg/kg bolus + 5 mg/kg for 45 min via a pulmonary artery catheter) plus LR solution (2x shed blood, IV). Arterial blood gases, hemoglobin levels, MAP, cardiac index, systemic vascular resistance index, pulmonary vascular resistance index, oxygen delivery, oxygen consumption, and oxygen extraction ratio (O₂ER) were measured serially. No differences in blood loss, hemoglobin, and MAP were observed. Pulmonary PTX increased cardiac index to levels more than baseline (P = 0.012) and decreased systemic vascular resistance index and pulmonary vascular resistance index to levels less than baseline (P < 0.0001). Pulmonary PTX increased oxygen delivery and oxygen consumption to baseline levels. Postresuscitation O₂ER levels in LR-treated animals remained more than baseline (P < 0.0001). Systemic and pulmonary PTX significantly decreased O₂ER compared with shock levels. PTX resuscitation is superior compared with LR solution alone. Intraarterial pulmonary PTX administration is safe, and improves cardiac performance as well as O₂ utilization.

IMPLICATIONS: This study shows that a novel route (via the pulmonary circulation) used to administer pentoxifylline after hemorrhagic shock leads to superior cardiac performance in comparison with administration via lactated Ringer’s solution or IV systemic pentoxifylline.

This article has been cited by other articles:

				R. J. Cruz Jr, M. M. Yada-Langui, L. F. P. de Figueiredo, S. Sinosaki, and M. R. e Silva The synergistic effects of pentoxifylline on systemic and regional perfusion after hemorrhage and hypertonic resuscitation. Anesth. Analg., May 1, 2006; 102(5): 1518 - 1524. [Abstract] [Full Text] [PDF]